BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5814610)

  • 1. [Radiotherapy of brain tumors].
    Sano K
    Nihon Ishikai Zasshi; 1969 Feb; 61(3):283-99. PubMed ID: 5814610
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of the combined use of radiosensitizing agents on radiotherapy of malignant encephaloma].
    Hoshino T
    Rinsho Hoshasen; 1968 Nov; 13(11):885-91. PubMed ID: 4304555
    [No Abstract]   [Full Text] [Related]  

  • 3. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study.
    Kankaanranta L; Seppälä T; Koivunoro H; Välimäki P; Beule A; Collan J; Kortesniemi M; Uusi-Simola J; Kotiluoto P; Auterinen I; Serèn T; Paetau A; Saarilahti K; Savolainen S; Joensuu H
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):369-76. PubMed ID: 21236605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current information on the treatment in neurosurgery].
    Sano K
    Geka Chiryo; 1971 Mar; 24(3):274-81. PubMed ID: 4927620
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of radiosensitizing agents in radiotherapy].
    Franke HD
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:199-201. PubMed ID: 4115508
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of BAR therapy in a case of malignant glioma with extracranial metastasis].
    Kanno T; Moriyama M; Kagawa M; To T; Ishimori S
    No To Shinkei; 1970 Oct; 22(10):1187-91. PubMed ID: 5536188
    [No Abstract]   [Full Text] [Related]  

  • 7. [Accumulation of carborane-series compounds in animal tissues during neutron-capture therapy].
    Spryshkova RA; Brattsev VA; Sherman TL; Stanko VI
    Med Radiol (Mosk); 1981 Jul; 26(7):51-5. PubMed ID: 7289807
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.
    Schinazi RF; Hurwitz SJ; Liberman I; Juodawlkis AS; Tharnish P; Shi J; Liotta DC; Coderre JA; Olson J
    Clin Cancer Res; 2000 Feb; 6(2):725-30. PubMed ID: 10690559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and experimental results of interstitial Curie-therapy combined with radiosensitizing agents in DS carcinoma of the rat and in infiltrating brain neoplasms].
    Mundinger F
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:201. PubMed ID: 4341101
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of malignant brain tumors by the intrathecal administration of BAR (EUdR-antimetabolite-radiation)].
    Takakura K; Matsutani M; Koyama Y; Sing OK
    No To Shinkei; 1972 May; 24(5):585-93. PubMed ID: 4340910
    [No Abstract]   [Full Text] [Related]  

  • 11. Boron neutron capture therapy for murine malignant gliomas.
    Saris SC; Solares GR; Wazer DE; Cano G; Kerley SE; Joyce MA; Adelman LS; Harling OK; Madoc-Jones H; Zamenhof RG
    Cancer Res; 1992 Sep; 52(17):4672-7. PubMed ID: 1511433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiosensitizers for brain tumors--study of radiotherapy].
    Sano K; Hoshino T; Nagai M; Tsuchida T; Sato F
    No To Shinkei; 1967 Apr; 19(4):339-44. PubMed ID: 6072673
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumour radiosensitization with the halogenated pyrimidines 5'-bromo- and 5'-iododeoxyuridine.
    Epstein AH; Cook JA; Goffman T; Glatstein E
    BJR Suppl; 1992; 24():209-14. PubMed ID: 1290703
    [No Abstract]   [Full Text] [Related]  

  • 14. [Trial and results of improved radiotherapy for cancer. 5. Radiotherapy with simultaneous administration of radio-sensitizing agents. Administration of halogenated pyrimidine].
    Tanaka N; Takahashi M
    Nihon Rinsho; 1972 Dec; 30(12):2655-8. PubMed ID: 4675997
    [No Abstract]   [Full Text] [Related]  

  • 15. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
    Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
    Sano K; Hoshino T; Nagai M
    J Neurosurg; 1968 Jun; 28(6):530-8. PubMed ID: 4233585
    [No Abstract]   [Full Text] [Related]  

  • 17. Halogenated pyrimidines as radiosensitizers for high grade glioma: revisited.
    Rodriguez R; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):859-62; discussion 865. PubMed ID: 1651310
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radiation sensitization of brain neoplasms by haloid analogs of pyrimidine bases].
    Lokshina AM; Pelevina II
    Med Radiol (Mosk); 1973 Mar; 18(3):70-7. PubMed ID: 4267617
    [No Abstract]   [Full Text] [Related]  

  • 19. Working group on optimization of radiation dose delivery.
    Wambersie A; Feinendegen LE
    Basic Life Sci; 1989; 50():277-84; discussion 284-97. PubMed ID: 2751615
    [No Abstract]   [Full Text] [Related]  

  • 20. Boron neutron capture therapy at the crossroads: challenges and opportunities.
    Barth RF
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S3-6. PubMed ID: 19467879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.